Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen- activated protein kinase-dependent pathway

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 2149-2155

  Ihn, H ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALPHOSTIN C; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ONCOSTATIN M; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN FIBROBLAST; WOUND HEALING;

EID: 0034664022     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.2149     Document Type: Article

References (49)

1. Cutaneous tissue repair: Basic biological considerations
2. Transforming growth factor-β: The dark side of tissue repair
3. Mitogenic effect of fibroblast growth factor on early passage cultures of human murine fibroblasts
4. Human epidermal growth factor: Isolation and chemical and biological properties
5. Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate
6. Cathectin and tumor necrosis factor as two sides of the same biological coin
7. Human fibroblasts synthesize elevated levels of extracellular matrix protein in response to interleukin 4
8. Differential regulation of collagen, glycosaminoglycan, fibronectin and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-α and β and tumor necrosis factor-α and β
9. Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6
10. A strategy for determining the pathogenesis of systemic sclerosis
11. Immunological demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma
12. Activation of collagen gene expression in keloids: Co-localization of type I and type VI collagen and transforming growth factor-β1 mRNA
13. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes: Synergistic antiproliferative activity of transforming growth factor-β1, interferon-γ, and oncostatin M for human melanoma cells
14. Oncostatin M is a differential factor for myeloid leukemia cells
15. Oncostatin M is a member of a cytokine family that includes leukemia- inhibitory factor, granulocyte colony-stimulating factor, and interleukin-6
16. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
17. Dual oncostatin M (OSM) receptors: Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
18. Regulation of cell growth by recombinant oncostatin M
19. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells
20. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells
21. Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site
22. Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: Insensitivity of sclerodermal and keloidal fibroblasts
23. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture
24. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts
25. Developmental abnormalities in mice transgenic for bovine oncostatin M
26. Oncostatin M
27. Transcriptional regulation of the human α2(I) collagen gene: Combined action of upstream stimulatory and inhibitory cis-acting elements
28. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins
29. Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes
30. Tyrosine dephosphorylation of nuclear proteins mimics transforming growth factor β1 stimulation of α2(I) collagen gene expression
31. Sp3 is a transcriptional activator of the human α2(I) collagen gene
32. Activation of transcription by IFN-γ: Tyrosine phosphorylation of a 91-kD DNA binding protein
33. Regulation of IL-6 expression by oncostatin M
34. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42(MAPK)/ERK-2 in Kaposi's cells: Evidence that this pathway is important in Kaposi's cell growth
35. P38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated cell proliferation but not differentiation
36. Interleukin 6 and its receptor: A paradigm for cytokines
37. Regulation of cell growth by recombinant oncostatin-M
38. The role of lymphocytes in wound healing
39. Lymphocytes in the skin of patients with progressive systemic sclerosis
40. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily
41. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
42. Parallel signal processing among mammalian MAPKs
43. Mitogen-activated protein kinases p42(mapk) and p44(mapk) are required for fibroblast proliferation
44. Nuclear localization and regulation of ERK- and RSK-encoded protein kinases
45. A synthetic inhibitor of the mitogen-activated protein kinase cascade
46. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
47. Diversity in function and regulation of MAP kinase pathways
48. The stress-activated protein kinase sub-family of c-jun kinases
49. Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts